World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
23764
World Ranking
2473
National Ranking
1182

Aravinda M. de Silva publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Aravinda M. de Silva sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 205 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Aravinda M. de Silva D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Aravinda M. de Silva sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Aravinda M. de Silva is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily falls within the field of Medicine, with a focus on several subfields including Infectious Diseases, Public Health, Environmental and Occupational Health, Molecular Biology, Epidemiology, and Obstetrics and Gynecology.

The scientist's work covers a range of topics related to infectious diseases, with prominent areas including mosquito-borne diseases and control, viral infections and vectors, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, viral infections and outbreaks research, vaccines and immunoinformatics approaches, and malaria research and control.

Aravinda M. de Silva has contributed to multiple recent papers, including:

  • Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals (2020, Cell)
  • The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients (2020, Science Immunology)
  • Zika virus infection enhances future risk of severe dengue disease (2020, Science)
  • Severe Dengue Epidemic, Sri Lanka, 2017 (2020, Emerging infectious diseases)
  • A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans (2021, Nature Communications)

Their frequent collaborators include Ralph S. Baric, Lakshmanane Premkumar, Ramesh Jadi, Alena J. Markmann, and Yixuan J. Hou.

The main publication venues for this scientist's work feature a wide spectrum of respected platforms, such as UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), mSphere, PLoS ONE, and Emerging infectious diseases.

Best Publications

  • Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

    Alba Grifoni;Daniela Weiskopf;Sydney I. Ramirez;Sydney I. Ramirez;Jose Mateus

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

    Jose Mateus;Alba Grifoni;Alison Tarke;John Sidney

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

    Lakshmanane Premkumar;Bruno Segovia-Chumbez;Ramesh Jadi;David R. Martinez

  • The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

    Martina Beltramello;Katherine L. Williams;Cameron P. Simmons;Annalisa Macagno

  • Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

    Daniela Weiskopf;Michael A. Angelo;Elzinandes L. de Azeredo;John Sidney

  • Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus

    William B. Messer;Duane J. Gubler;Eva Harris;Kamalanayani Sivananthan

  • Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

    A M de Silva;S R Telford;L R Brunet;S W Barthold

  • Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

    Ruklanthi De Alwis;Scott A. Smith;Nicholas P. Olivarez;William B. Messer

  • The Human Antibody Response to Dengue Virus Infection

    Wahala M. P. B. Wahala;Aravinda M. de Silva

  • Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.

    Jun Ohnishi;Joseph Piesman;Aravinda M. de Silva

  • Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding

    A M De Silva;E Fikrig

  • Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

    W.M. P. B. Wahala;Annette A. Kraus;Laura B. Haymore;Mary Ann Accavitti-Loper

  • Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity.

    Daniela Weiskopf;Derek J. Bangs;John Sidney;Ravi V. Kolla

  • Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.

    Utpal Pal;Aravinda M. de Silva;Ruth R. Montgomery;Durland Fish

  • Zika virus infection enhances future risk of severe dengue disease

    Leah C. Katzelnick;César Narvaez;Sonia Arguello;Brenda Lopez Mercado

  • Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

    Guntur Fibriansah;Kristie D. Ibarra;Thiam-Seng Ng;Scott A. Smith

  • In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.

    Ruklanthi de Alwis;Martina Beltramello;William B. Messer;Soila Sukupolvi-Petty

  • Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus

    Petraleigh Pantoja;Erick X. Pérez-Guzmán;Idia V. Rodríguez;Laura J. White

  • A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

    Guntur Fibriansah;Joanne L. Tan;Scott A. Smith;Ruklanthi De Alwis

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Eva Harris
Eva Harris University of California, Berkeley
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Daniela Weiskopf
Daniela Weiskopf La Jolla Institute For Allergy & Immunology
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Bjoern Peters
Bjoern Peters La Jolla Institute For Allergy & Immunology
Anna P. Durbin
Anna P. Durbin Johns Hopkins University
Benjamin J. Doranz
Benjamin J. Doranz University of Pennsylvania
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various healthcare and research careers. For those interested in clinical roles with a focus on mental health, online nurse practitioner programs offer flexible paths to advance your education. Finding the easiest online nurse practitioner programs can be a good starting point for busy professionals seeking a manageable curriculum.

Specifically, mental health nursing is a growing field with increasing demand. Programs recognized for having the best online psychiatric mental health nurse practitioner programs provide solid clinical placement opportunities, critical for real-world experience.

Cost is always a consideration when selecting a degree program. Many students prioritize the cheapest online pmhnp programs to balance quality education with financial feasibility.

Finally, understanding potential earnings helps guide career choices. Discovering how much do dnp nurses make sheds light on salary expectations across different states, assisting candidates in making informed decisions about their future.

Best Scientists Citing Aravinda M. de Silva

Trending Scientists

Recently Published Articles